MNV
Market News Video
MNV MNV 10 Bargains You Can Buy Cheaper Than Insiders Did
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

This ETF Holds Stocks Insiders Want to Own
Wednesday, April 18, 9:30 AM ET, by Market News Video Staff

A look at the weighted underlying holdings of the First Trust Water ETF (FIW) shows ...

iRhythm Technologies Enters Oversold Territory (IRTC)
Wednesday, April 25, 12:18 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Glaukos Breaks Above 200-Day Moving Average - Bullish for GKOS
Thursday, April 26, 4:28 PM ET, by Market News Video Staff

In trading on Thursday, shares of Glaukos Corp (GKOS) crossed above their 200 day moving ...

Peek Under The Hood: XHE Has 10% Upside
Wednesday, May 2, 8:59 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Lantheus Holdings (LNTH) Shares Cross Above 200 DMA
Wednesday, May 2, 11:51 AM ET, by Market News Video Staff

In trading on Wednesday, shares of Lantheus Holdings Inc (LNTH) crossed above their 200 day ...

Idexx Laboratories, Inc. Breaks Below 200-Day Moving Average - Notable for IDXX

By Market News Video Staff, Tuesday, February 12, 5:10 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Tuesday, shares of Idexx Laboratories, Inc. (NASDAQ:IDXX) crossed below their 200 day moving average of $92.93, changing hands as low as $92.85 per share. Idexx Laboratories, Inc. shares are currently trading off about 0.6% on the day. The chart below shows the one year performance of IDXX shares, versus its 200 day moving average:

Idexx Laboratories, Inc. 200 Day Moving Average Chart

Looking at the chart above, IDXX's low point in its 52 week range is $81.31 per share, with $101.18 as the 52 week high point that compares with a last trade of $92.93.


Special Offer: Find out what Frank Bifulco is holding in the Dividend OverDrive Portfolio with a free 30 day trial and a 20% off coupon from Forbes

According to the ETF Finder at ETF Channel, IDXX makes up 2.17% of the SPDR S&P Health Care Equipment ETF (NYSE:XHE) which is trading up by about 0.1% on the day Tuesday.

See what other ETFs contain IDXX
See what other stocks are held by XHE


This Article's Word Cloud:   According   Average   Below   Bifulco   Care   Channel   Crossing   Dividend   ETFs   Equipment   Find   Finder   Forbes   Frank   Health   IDXX   Idexx   Laboratories   Looking   Moving   NYSE   Offer   OverDrive   Portfolio   SPDR   Special   Start   Stocks   Their   Tuesday   about   above   average   below   changing   chart   compares   contain   coupon   crossed   currently   moving   other   point   share   shares   trading   week   what   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Idexx Laboratories, Inc. Breaks Below 200-Day Moving Average - Notable for IDXX | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.